Business Domain – 1000 Webu http://1000webu.com/ Wed, 15 Sep 2021 09:13:54 +0000 en-US hourly 1 https://wordpress.org/?v=5.8 https://1000webu.com/wp-content/uploads/2021/05/default-138x136.png Business Domain – 1000 Webu http://1000webu.com/ 32 32 Global mobile augmented reality market to raise $ 184.61 https://1000webu.com/global-mobile-augmented-reality-market-to-raise-184-61/ https://1000webu.com/global-mobile-augmented-reality-market-to-raise-184-61/#respond Wed, 15 Sep 2021 08:21:19 +0000 https://1000webu.com/global-mobile-augmented-reality-market-to-raise-184-61/ Portland, OR, September 15, 2021 (GLOBE NEWSWIRE) – According to the report published by Allied Market Research, the mobile augmented reality market is expected to reach $ 184.61 billion by 2030, up from $ 12.61 billion in 2020, with a CAGR of 31.40% from 2021 to 2030. The report presents information on key drivers, constraints […]]]>

Portland, OR, September 15, 2021 (GLOBE NEWSWIRE) – According to the report published by Allied Market Research, the mobile augmented reality market is expected to reach $ 184.61 billion by 2030, up from $ 12.61 billion in 2020, with a CAGR of 31.40% from 2021 to 2030. The report presents information on key drivers, constraints and augmented reality mobile (AR), market opportunities, as well as with a detailed impact analysis.

The high use of mobile AR in the healthcare sector, the growth of the retail sector and the increasing adoption of AR technology by the tourism and education industry are the Key factors contributing to the growth of the global mobile augmented reality (AR) market. However, the limited user interface affecting the browsing performance of AR applications is a factor hampering the growth of the increased mobile market. On the contrary, the increase in the adoption of AR smart glasses is expected to create opportunities for the mobile augmented reality (AR) industry.

Download a free sample report (get a detailed analysis in PDF format – 310 pages): https://www.alliedmarketresearch.com/request-sample/13489

Covid-19 scenario:

· The sudden decline in infrastructure development is expected to hamper market growth for the consumer, education and tourism sectors.
· Slower OEM production and reduced demand for mobile devices and other electronic devices dragged down the mobile AR market slightly.
· Budget cuts and delays in planned projects in various industries have hampered the global economy.

The report segments the global mobile augmented reality (AR) market on the basis of component, device type, application, and region.

On the basis of applications, the consumer segment accounted for the largest market share in 2020, contributing more than two-thirds of the total share, and is expected to maintain its lead throughout the forecast period. On the other hand, the business segment is expected to experience the fastest CAGR of 38.4% from 2021 to 2030.

Interested in acquiring the data? Inquire Here @ https://www.alliedmarketresearch.com/purchase-enquiry/13489

Based on device type, the smartphone segment contributed the largest share in 2020, accounting for more than half of the global mobile augmented reality market. The same segment is expected to dominate the market with the manifestation of the highest CAGR of 32.6% from 2021 to 2030.

Depending on the region, North America contributed to the highest share in 2020, holding around two-fifths of the total share, and is expected to remain in the lead throughout the forecast period. On the other hand, Asia-Pacific is expected to exhibit the fastest CAGR of 32.8% during the forecast period.
Get a detailed analysis of the impact of COVID-19 on the Mobile Augmented Reality (AR) Market: https://www.alliedmarketresearch.com/request-for-customization/13489?reqfor=covid

Major mobile augmented reality market players analyzed in the research include Microsoft Corporation, Blippar.Com Ltd., Qualcomm Inc., Google, Apple, Magic Leap, Groove Jones, Wikitude, Samsung Electronics Co. Ltd. and Marxent Labs.

About Us:

Allied Market Research (AMR) is a full-service market research and business consulting division of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global businesses as well as medium and small businesses with unmatched quality of “market research reports” and “business intelligence solutions”. AMR has a focused vision to provide business information and advice to help its clients make strategic business decisions and achieve sustainable growth in their respective market area.

Pawan Kumar, CEO of Allied Market Research, leads the organization towards delivering high quality data and information. We have professional relationships with various companies, which helps us extract market data which helps us generate accurate research data tables and confirm the highest accuracy in our market forecast. Each of the data presented in the reports we publish is extracted through primary interviews with senior officials of the main companies in the field concerned. Our secondary data sourcing methodology includes in-depth online and offline research and discussions with industry-savvy professionals and analysts.

        


Source link

]]>
https://1000webu.com/global-mobile-augmented-reality-market-to-raise-184-61/feed/ 0
Test your company’s creativity with edition 7 of our quiz! https://1000webu.com/test-your-companys-creativity-with-edition-7-of-our-quiz/ https://1000webu.com/test-your-companys-creativity-with-edition-7-of-our-quiz/#respond Sat, 11 Sep 2021 05:17:05 +0000 https://1000webu.com/test-your-companys-creativity-with-edition-7-of-our-quiz/ This weekly quiz of Your story tests your domain knowledge, business acumen and lateral thinking skills (see last week’s quiz here). In this seventh edition of the quiz, we present five issues addressed by real-life entrepreneurs in their startup journey. What would you do if you were in their shoes? At the end of the […]]]>

This weekly quiz of Your story tests your domain knowledge, business acumen and lateral thinking skills (see last week’s quiz here). In this seventh edition of the quiz, we present five issues addressed by real-life entrepreneurs in their startup journey.

What would you do if you were in their shoes? At the end of the quiz, you will find out what the entrepreneurs themselves have actually done. Would you do things differently?

Q1: E-commerce success

UX, UI, and service design are effective approaches to improving the e-commerce experience. Much attention has been paid to the quality of products on sale, ratings and reviews, and even video experiences to improve product rating. Addressing an additional process can increase ecommerce volumes, but is often overlooked – what is that process?

Q2: Durable packaging

Waste from packaging materials is a serious cause of pollution and damage to health. Several alternative approaches have been proposed, such as paper or biodegradable plastic. But there is another solution, which is a nice example of circular packaging, it can be recycled endlessly. What is this material?

Q3: Rural trade

E-commerce has been an effective channel for a wide range of products, especially during the pandemic period. However, for categories such as consumer electronics, rural areas do not have large electronics stores and e-commerce delivery can take up to a week. What’s the best way to sell electronics in rural India?

Q4: Core technologies

The convergence of analytics, AI, ML and IoT is fundamental for many industries. It offers a wide range of capabilities in operational efficiency, personalization and customer experience. There is another cross-cutting technology that is slowly but surely emerging – what is it?

Q5: The challenge of success

It is commonly said that “Nothing succeeds like success, ” and large companies are well positioned to succeed in the future through their accumulation of best practices. However, being successful also comes with its own challenges, as evidenced by the demise of previously dominant companies and products. What is the problem with success, and how can it be overcome?

Answers!

Congratulations on making it this far! But there’s more to come – answers to these five questions (below), as well as links to articles with more details on entrepreneurs’ solutions. Good reading, Good learning, and good creation!

A1: E-commerce success

“As many as 95% of customers tend to buy from the brand again if their return process is easier,” advises Gaurav Gupta, Co-founder of Shipway. “Provide your customers with the self-service portal, a simpler and more efficient way to return their orders,” he adds. Read more here.

In fact, consideration of returns due to dissatisfied customers should be done from the start of e-commerce and D2C activities. “Sellers must build a certain percentage of returns into the cost structure,” suggests Sugam Jain, Founder and CEO, Shyplite. Find more tips here.

A2: Sustainable packaging

“Aluminum beverage cans are the perfect example of a circular packaging solution because they can be recycled endlessly without any loss in quality,” observes Amit Lahoti, Vice President and General Manager, Ball Beverage Packaging, India. “A great proof of this is the fact that approximately 75% of all aluminum ever produced in the world is still used today,” he adds. In such “true recycling”, materials retain their economic value and function. To learn more, click here.

A3: Rural trade

The practice of ‘shops on wheels’ has been around for some time, but has been adopted into the consumer electronics space in rural India by KS Bhatia, Founder of the aptly named Figgital (“phygital”). It uses a combination of stores in small towns and vans to bring the retail experience to the doorsteps of consumers in rural areas. Read more here.

A4: Basic technologies

Augmented Reality (AR) finds a wide range of applications in organizational L&D and product visualization. “India is witnessing disruptive possibilities in using AR for industries ranging from real estate to automobiles, healthcare to education and more,” observes Vaideeswaran Sethuraman, Founder, Divum Services aux entreprises. The Indian XR market has been estimated by TechSci Research at $ 1.83 billion for fiscal 2020. Read more here.

A5: The challenge of success

“One of the negative consequences of success is arrogance”, warns Nitin Seth, CEO of Incedo and author of Winning in the Digital Age: The Seven Building Blocks of a Successful Digital Transformation (see my book review here).

A major learning challenge is pride, over-reliance on past knowledge, he cautions. Humility, strong circles and ethics can be corrective factors.

YourStory also published the paperback “Proverbs and quotes for entrepreneurs: a world of inspiration for startups” as a creative and motivating guide for innovators (downloadable as apps here: Apple, Android).


Source link

]]>
https://1000webu.com/test-your-companys-creativity-with-edition-7-of-our-quiz/feed/ 0
Asiance and Mobile now sign Memorandum of Understanding for Northeast Asia https://1000webu.com/asiance-and-mobile-now-sign-memorandum-of-understanding-for-northeast-asia/ https://1000webu.com/asiance-and-mobile-now-sign-memorandum-of-understanding-for-northeast-asia/#respond Wed, 08 Sep 2021 06:39:00 +0000 https://1000webu.com/asiance-and-mobile-now-sign-memorandum-of-understanding-for-northeast-asia/ SEOUL, South Korea & SHANGHAI – (COMMERCIAL THREAD) – Asiance, a Seoul and Tokyo-based branded technology company, and Mobile Now, a Shanghai-based full-service mobile platform agency, have entered into a strategic partnership agreement by signing a memorandum of understanding OK. Global brands are increasingly focusing on Asian markets by developing strategic development on local platforms […]]]>

SEOUL, South Korea & SHANGHAI – (COMMERCIAL THREAD) – Asiance, a Seoul and Tokyo-based branded technology company, and Mobile Now, a Shanghai-based full-service mobile platform agency, have entered into a strategic partnership agreement by signing a memorandum of understanding OK.

Global brands are increasingly focusing on Asian markets by developing strategic development on local platforms such as KakaoTalk, Line or WeChat to reach their local audience. As experts in this field, Asiance and Mobile Now will use this partnership to provide comprehensive answers to the digital marketing needs of their customers in the region.

Indeed, through this agreement, the two companies have decided to exchange knowledge on local digital ecosystems and to share talents and resources for collaboration opportunities. Through this, they will create synergies to help international brands navigate their digital transformation journey in China, Japan and Korea. “We are delighted to enter into this partnership with Mobile Now. We look forward to combining Asiance’s knowledge of Korea and Japan with Mobile Now’s expertise in the Chinese market, ”said Olivier Mouroux, CEO of Asiance.

Thomas Meyer, co-founder of Mobile Now said: “China has become the digital laboratory of the world and we, Mobile Now, are one of the few agencies keeping pace with changing technologies, while repeatedly deploying successful mobile platforms. We are very proud to partner with Asiance. We believe that together we can build the basis of a growing alliance of agencies and facilitators who will bring together more like-minded partners, who truly understand the social transaction, the digital wave ”.

About Asiance

Asiance started in Seoul in 2004 and has since established its presence in digital marketing, CX and consulting for global brands that have entered Asia, and in particular Korea. Asiance has worked with approximately 350 brands for 16 years, establishing a close relationship with global luxury brands and becoming a leader in the digital marketing landscape in Korea.

By repositioning itself as Asia’s premier brand-tech partner in 2020, the company is expanding its activities into new areas to deliver innovative digital services that combine technology and creativity to ultimately create positive impact. This agreement embodies that vision, further pushing Asiance’s mission to connect East and West and brand and technology.

About Mobile Now

Mobile Now was founded in Shanghai in 2009 to imagine and create mobile solutions in the Chinese market, for global and local brands. Since their inception, they have set up delivery centers in Hangzhou and Changsha and a network office in Singapore.

Mobile Now is passionate about designing and implementing market-ready mobile solutions based on the latest emerging technologies. Mobile Now’s expertise extends from Mcommerce, CRM and clienteling, through the tailor-made solutions of the WeChat Mini program, native applications and mobile web platforms.

They have a strong focus on retail and luxury, as well as a broader knowledge of the automotive, pharmaceutical and hospitality industry. Their solutions are either fully integrated into the customer’s system infrastructure or stand-alone as tailor-made solutions to meet specific needs of China.


Source link

]]>
https://1000webu.com/asiance-and-mobile-now-sign-memorandum-of-understanding-for-northeast-asia/feed/ 0
US helps PH strengthen maritime knowledge – Philippine Canadian Inquirer https://1000webu.com/us-helps-ph-strengthen-maritime-knowledge-philippine-canadian-inquirer/ https://1000webu.com/us-helps-ph-strengthen-maritime-knowledge-philippine-canadian-inquirer/#respond Sat, 04 Sep 2021 03:11:16 +0000 https://1000webu.com/us-helps-ph-strengthen-maritime-knowledge-philippine-canadian-inquirer/ THE PARTNERS. Members of the Philippine Coast Guard observe the launch of a small unmanned aircraft system from the flight deck of the USCG Cutter Munro during a maritime engagement August 31, 2021, in the western Philippine Sea. Operating under the tactical control of the U.S. 7th Fleet, the cutter and crew engage in professional […]]]>
THE PARTNERS. Members of the Philippine Coast Guard observe the launch of a small unmanned aircraft system from the flight deck of the USCG Cutter Munro during a maritime engagement August 31, 2021, in the western Philippine Sea. Operating under the tactical control of the U.S. 7th Fleet, the cutter and crew engage in professional exchanges and capacity building exercises with partner nations and patrol and conduct operations as directed. (Photo courtesy of Marine Corps Sgt. Kevin Rivas, US Coast Guard via PNA)

MANILA – The United States Coast Guard (USCG) is helping its Filipino counterpart build knowledge of the country’s maritime domain.

USCG Vice Admiral Michael McAllister said in a teleconference on Friday that Washington DC wanted to give Manila the ability and the ability “to spend more time beyond its shores.”

The USCG and the Philippine Coast Guard recently concluded joint exercises in the West Philippine Sea, but McAllister clarified that this does not necessarily mean there was an intention to send a message.

“I’m not going to say that the activity near the Scarborough Shoals was necessarily meant to send a message; but when you think of the Philippines’ claim to their waters, that opportunity to take them further away from shore, do maritime outreach and – where appropriate – enforce laws and treaties within their exclusive economic zone. (ZEE), it just requires us to get them away from the shore, ”he said.

Scarborough Shoal or Masinloc’s Bajo was the site of a tense clash between China and the Philippines in 2012. The shoal is about 124 nautical miles off the coast of Zambales.

McAllister said maritime domain knowledge implies an increased ability to identify activities taking place in a country’s sovereign waters, “with the idea that you would be able to respond to any threat.”

Apart from this, the USCG and PCG had also organized a series of search and rescue and communications exercises as well as small boat operations and multi-ship maneuvers at sea.

USCG Cutter Munro arrived in Subic Bay in Zambales on Tuesday following maritime exercises in the western Philippine Sea. It left its home port of Alameda, Calif., In July for a multi-month deployment to the Western Pacific.

Munro, a 418-foot national security cutter, operates under the tactical control of the U.S. 7th Fleet and participates in capacity-building exercises with partner nations.


Source link

]]>
https://1000webu.com/us-helps-ph-strengthen-maritime-knowledge-philippine-canadian-inquirer/feed/ 0
Lipid Contract Manufacturing Market, 2030 – ResearchAndMarkets.com | Business https://1000webu.com/lipid-contract-manufacturing-market-2030-researchandmarkets-com-business/ https://1000webu.com/lipid-contract-manufacturing-market-2030-researchandmarkets-com-business/#respond Wed, 01 Sep 2021 08:07:21 +0000 https://1000webu.com/lipid-contract-manufacturing-market-2030-researchandmarkets-com-business/ DUBLIN – (BUSINESS WIRE) – Sep 1, 2021– The “Lipid Contract Manufacturing Market by Type of Lipids, Triglycerides, Sphingolipids, Neutral Lipids, Others), Company Size, Scale of Operation and Key Geographies: Industry Trends and Global Forecast, 2021- 2030 “ report was added to ResearchAndMarkets.comoffer. The “Lipid Contract Manufacturing Market Report 2021-2030” report presents an in-depth study […]]]>

DUBLIN – (BUSINESS WIRE) – Sep 1, 2021–

The “Lipid Contract Manufacturing Market by Type of Lipids, Triglycerides, Sphingolipids, Neutral Lipids, Others), Company Size, Scale of Operation and Key Geographies: Industry Trends and Global Forecast, 2021- 2030 “ report was added to ResearchAndMarkets.comoffer.

The “Lipid Contract Manufacturing Market Report 2021-2030” report presents an in-depth study of the current market landscape and future potential of the contract lipid manufacturing market. The study includes an in-depth analysis, highlighting the capacities of contractual service providers engaged in this area.

About 90% of drug candidates under development and nearly 40% of pharmacological products marketed have been associated with solubility and / or permeability problems. In this context, given modern regulatory standards, a large number of potential therapeutic avenues fail to pass the clinical evaluation phase and enter the market, due to low bioavailability.

Over time, innovators in the biopharmaceutical industry have developed a number of ways to improve / increase the physicochemical properties and ultimately the drug-like behavior of pharmacological substances. Among other alternatives, lipid nanoparticles and the use of various lipid-based excipients (which improve permeability across biological membranes) have caught the attention of drug developers.

In fact, the new mRNA-based COVID-19 vaccines use lipid nanoparticles to deliver the active ingredient of the preventive intervention to the required site of action, which is found in the target antigen-presenting cells in the body. human. In addition, many other companies are using the aforementioned lipid-based solutions to reformulate existing product candidates to improve their bioavailability. As a result, the demand for lipid drug carriers and excipients has increased dramatically.

However, for some of the lipids that have medical applications, the associated manufacturing processes are very complex, capital intensive, and face multiple challenges. Some of the major issues associated with the production of GMP grade lipids include the need for specialized expertise (especially in the case of lipid nanoparticles), the lack of facilities with the infrastructure and capacity to produce the lipid. required quality of substances, as well as storage, safety and efficacy concerns.

One of the primary objectives of the report was to assess the current opportunity and future potential of the Lipid Contract Manufacturing market over the next decade. We have provided an informed estimate of the likely evolution of the market in the short, medium and long term, for the period 2021-2030.

The annual projections of current and future opportunities have been further segmented based on

  • Lipid type (liposomes / lipid nanoparticles, phospholipids, pegylated lipids, ionizable lipids (cationic / anionic lipids), triglycerides, sphingolipids, neutral lipids and others)
  • Company size (small, medium and large / very large)
  • Operating scale (preclinical, clinical and commercial)
  • To account for future uncertainties in the market and to add robustness to our model, we have provided three forecast scenarios, outlining conservative, baseline and optimistic tracks for the market movement.
  • The opinions and views presented in the report have also been influenced by discussions held with key industry stakeholders.

The report contains detailed transcripts of interviews with the following people:

  • Asha Van Rooijen (Founder and CEO, Liposoma)
  • Rahul Keswani (Associate Director, Formulation Development, Exelead)
  • John Riley (Director, Chemical Process Development, BioVectra) and Clement Mugabe (Acting Director, Biotechnology Process Development, BioVectra)

Answers to key questions

  • Who are the main lipid subcontractors involved in this field?
  • Which regions of the world are considered key hubs for the contract manufacturing of lipid products?
  • What types of partnership models are commonly adopted by players in this industry?
  • What different expansion initiatives have been undertaken by contract lipid manufacturers?
  • What factors are likely to influence the decision to manufacture lipids in-house or contracted out?
  • What is the current global lipid manufacturing capacity (in liters) of subcontractors?
  • How are current and future market opportunities likely to be distributed among key market segments?

Companies mentioned

  • 2-BBB Drugs
  • Abbott Laboratories
  • AbbVie Contract Manufacturing
  • ABITEC
  • ADM-SIO
  • Ajinomoto Biopharmaceutical Services
  • Alnylam Pharmaceuticals
  • Althea Technologies
  • Altum Pharmaceuticals
  • Amatsigroup
  • AmpTec
  • AMRI
  • Arbro Pharmaceutical
  • Arbutus Biopharma
  • Arcturus Therapeutics
  • Ardene
  • Aronex Pharmaceuticals (subsidiary of Agenus)
  • Pharmaceutical Ascendia
  • Astellas Pharma
  • Avanti Polar Lipids
  • B. Braun
  • BASF
  • Bausch Health (formerly Valeant Pharmaceuticals)
  • Bayer
  • Berna Biotech Pharma
  • Biochempeg
  • BioConnection
  • BioNTech
  • Bioserv
  • BioVectra
  • BioZone Laboratories
  • BOC Sciences
  • Boehringer Ingelheim
  • Bristol Myers Squibb
  • Britannia Pharmaceuticals
  • BSP Pharmaceutical
  • Biotech box
  • Camurus
  • CanSino organic products
  • Capsugel
  • Catalent
  • Chemical caiman
  • ChemConnection
  • Cipher Pharmaceuticals
  • Bioproducts cone
  • CordenPharma
  • Creative biolabs
  • Creative biostructure
  • Croda
  • Crucell
  • CuriRx
  • Daiichi sankyo
  • Dalton Pharmaceutical Services
  • Diethelm Keller Siber Hegner (DKSH)
  • DSM
  • Eisai
  • Pharmaceutical Elan
  • Empirical laboratories
  • Encapsula NanoSciences
  • Pharmaceutical Entos
  • Evonik
  • Execution
  • ForDoz Pharma
  • Scientific FormuMax
  • Fresenius Kabi
  • Fujifilm
  • Gattefosse
  • Genus Pharmaceuticals (acquired by STADA Arzneimittel)
  • Genzyme
  • GHO Capital
  • GlaxoSmithKline
  • Glenmark Pharmaceuticals
  • General practitioner
  • Helix BioPharma
  • HTD Biosystems
  • IMCD
  • Intas Pharmaceutical
  • Jamia Hamdard University
  • Pharmaceutical Jazz
  • Jina Pharma
  • Juniper Pharmaceuticals (acquired by Catalent)
  • KD Pharma
  • Keystone Nano
  • Kowa Pharmaceuticals
  • Kuecept
  • Lantheus medical imaging
  • Larodan
  • LATITUDE Pharmaceutical
  • Leading biosciences
  • Lipid systems
  • Lipidoma Life Sciences
  • Lipoid
  • LipoMedix
  • lipomize
  • LIPOSOME
  • lndchem International
  • Lonza
  • LSNE subcontracted manufacturing
  • Lubrizol
  • Lupine
  • Lypro Biosciences
  • Marine ingredients (KD Pharma)
  • Matinas BioPharma
  • Matreya
  • Memory secret
  • Merck
  • Merrimack pharmaceutical
  • Micro-sphere
  • PHARMACEUTICAL MIKA
  • Moderna
  • Biotech molecule
  • Nabros Pharma
  • Nagase Medical
  • NattoPharma
  • Nemus Biosciences
  • NeXstar Pharmaceuticals (acquired by Gilead Sciences)
  • NextPharma
  • Nippon Fine Chemical
  • NOF Europe
  • Novartis
  • Novavax
  • OPKO Health
  • Organon
  • Ozone Pharmaceuticals
  • Pacira pharmacy
  • Pfizer
  • Flagship drug delivery
  • International Pharmaceutical
  • Pharmacy
  • PharmaSol
  • Phosphorex
  • Pyramid pharmaceutical solutions
  • Scientific Polymun
  • Precision nanosystems
  • Quai Pharma
  • Quotient Sciences
  • Regulon
  • rock
  • Samyang Biopharmaceuticals
  • Sancilio Pharmaceutical
  • Sanofi Aventis
  • Schering-Plow
  • SciTech Development
  • Sequus Pharmaceuticals
  • Shochem (Shanghai)
  • Sirnaomics
  • SkyPharma
  • SoluBest
  • STA Pharmaceutical
  • Sucampo Pharmaceuticals
  • Sun Pharma
  • Syntagon
  • Scientific T&T
  • Takeda Pharmaceuticals
  • Therapeutic Heel
  • Tergus Pharma
  • Teva Pharmaceuticals
  • The Liposome Company (acquired by Elan Pharmaceuticals)
  • Transferra Nanosciences (acquired by Evonik)
  • ATS Biopharmacy
  • Univar Solutions
  • Pharmaceutical Validus
  • Valimenta
  • Pharmaceutical variants
  • VAV Life Sciences
  • VCARE biological laboratories
  • Vesifact
  • Vineland Environmental Laboratories
  • ViralClear Pharmaceuticals (subsidiary of BioSig)
  • Vitasome
  • Therapeutic VLP
  • Wyeth Pharmaceuticals
  • ZoneOne Pharma

For more information on this report, visit https://www.researchandmarkets.com/r/k2ozu0

View source version on businesswire.com:https://www.businesswire.com/news/home/20210901005403/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Director

press@researchandmarkets.com

For EST office hours, call 1-917-300-0470

For USA / CAN call toll free 1-800-526-8630

For GMT office hours, call + 353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH

SOURCE: Research and markets

Copyright Business Wire 2021.

PUB: 09/01/2021 04:07 / DISC: 09/01/2021 04:07

http://www.businesswire.com/news/home/20210901005403/en

Copyright Business Wire 2021.


Source link

]]>
https://1000webu.com/lipid-contract-manufacturing-market-2030-researchandmarkets-com-business/feed/ 0
Amit Dixit joins Zolo as CTO https://1000webu.com/amit-dixit-joins-zolo-as-cto/ https://1000webu.com/amit-dixit-joins-zolo-as-cto/#respond Fri, 27 Aug 2021 19:16:01 +0000 https://1000webu.com/amit-dixit-joins-zolo-as-cto/ In his new role, Dixit will lead the design, product development, technology strategy and program management teams at Zolo. Zolo, the leader in its category and the largest co-living brand in India, has appointed Amit Dixit as CTO. Dixit joins Zolo from Tata CLiQ, where he was a senior engineer. In his new role, Dixit […]]]>

In his new role, Dixit will lead the design, product development, technology strategy and program management teams at Zolo.


Zolo, the leader in its category and the largest co-living brand in India, has appointed Amit Dixit as CTO. Dixit joins Zolo from Tata CLiQ, where he was a senior engineer. In his new role, Dixit will lead the design, product development, technology strategy and program management teams at Zolo.

Amit brings with him over 21 years of experience in product and software development, large-scale platform management, technology roadmap development, cloud migration, and cloud strategy across business areas. activity such as banking, retail, ERP and e-commerce. Commenting on the appointment, Nikhil Sikri, CEO and Co-Founder of Zolo, said: “Technology is the backbone of Zolo and Dixit joins us at a very important time when customer engagement needs to be strengthened. His vast experience in the field will help us continue to deliver innovative and engaging experiences to our customers ”.

Commenting on his new role, Amit Dixit said: “I hope to make a significant contribution to leading and overseeing the technical roadmap, key functions and technical indicators of the company. I look forward to providing personalized solutions and world-class services through our technology-based co-living platform ”. At Zolo, technology is the heart of the business which focuses on customer experience and operational excellence.






Source link

]]>
https://1000webu.com/amit-dixit-joins-zolo-as-cto/feed/ 0
Major depressive disorders pipeline: insights into leadership https://1000webu.com/major-depressive-disorders-pipeline-insights-into-leadership/ https://1000webu.com/major-depressive-disorders-pipeline-insights-into-leadership/#respond Thu, 26 Aug 2021 00:00:00 +0000 https://1000webu.com/major-depressive-disorders-pipeline-insights-into-leadership/ Los Angeles, United States, Aug 25, 2021 (GLOBE NEWSWIRE) – Major Depressive Disorders Pipeline: Overview of Major Pharmaceutical Players, New Emerging Therapies, Clinical Trials and Future Perspectives | SearchInsight The Major Depressive Disorders pipeline is evolving with new therapies as well as reoriented therapies in the pipeline, as well as a better understanding of the […]]]>

Los Angeles, United States, Aug 25, 2021 (GLOBE NEWSWIRE) – Major Depressive Disorders Pipeline: Overview of Major Pharmaceutical Players, New Emerging Therapies, Clinical Trials and Future Perspectives | SearchInsight

The Major Depressive Disorders pipeline is evolving with new therapies as well as reoriented therapies in the pipeline, as well as a better understanding of the mechanisms of action.

DelveInsight’s Overview of the major depressive disorder (MDD) pipeline The report offers comprehensive coverage of the emerging therapeutic landscape at different stages of development, from preclinical to late stage, as well as dormant, inactive and abandoned therapeutic agents.

The Major Depressive Disorders Pipeline Reports provide a comprehensive picture of ongoing clinical trials, ongoing partnerships in the field, recent events in the space, and prospects for growth in the field of major depressive disorders.

Some of the highlights of the Major depressive disorders pipeline report:

  • The Major Depressive Disorders Pipeline report provides a rich analysis of 75+ key players and 75+ key therapies.
  • The Major Depressive Disorders pipeline includes therapies at different stages of the clinical phase, such as: Vraylar, PDC-1421, AV-101, AXS-05, Pramipexole, SAGE-217, LY03005, Seltorexant, PH10, PRAX-114, REL-1017, Caplyta, Lumateperone, and others, and many more are expected to enter the private label market over the next decade.
  • Some of the key companies engaged in strengthening the major depressive disorders pipeline are Axsome Therapeutics, Luye Pharma, Sage Therapeutics, Chase Therapeutics, Minerva Biosciences, Relmada Therapeutics, Praxis Precision Medicines, Intra-Cellular Therapies, among others.
  • In June 2021, Sage Therapeutics and Biogen announced the Phase III results of Zuranolone (WATERFALL study). The study met its primary endpoint, on day 15 zuranolone 50 mg showed a statistically significant and clinically significant reduction in depressive symptoms as measured by HAMD-17 (p = 0.0141) compared to placebo .
  • In June 2021, Small Pharma announced the extension of its Phase I / IIa clinical trial for its flagship product, SPL026, an N, N-dimethyltryptamine (“DMT”) treatment for major depressive disorder.

Sample request to learn more about therapies set to capture maximum patients @ Emerging therapies and predictions for major depressive disorder

Major depressive disorder (MDD) is one of the most common psychiatric disorders that results in persistent sadness, loss of interest or pleasure, lack of energy, decreased appetite and sleep, and even suicide, disrupting daily activities and psychosocial functions. It is the main cause of the disease burden in high income countries.

For more information on emerging drugs, visit Major depressive disorder pipeline analysis

Drugs in the pipeline for major depressive disorder

Medication Society Phase MoA RdA
Vraylar Allergan / Gedeon Richter Phase III Partial dopamine D2 receptor agonists Oral
PDC-1421 Biolite inc. Phase II Plasma membrane transport protein norepinephrine inhibitors Oral
AV-101 VistaGen Therapeutics Phase II NMDA receptor modulators Oral
AXS-05 Axsome Therapeutics Pre-registration Adrenergic receptor antagonists Oral
Pramipexole Therapeutic chase Phase II Dopamine D2 receptor agonists Oral
SAGE-217 Therapeutic sage Phase III GABA A receptor modulators Oral
LY03005 Luye Pharma Group Pre-registration Serotonin uptake inhibitors Oral
Seltorexant Minerva Therapeutics Phase III Orexin type 2 receptor antagonists Oral
PH10 VistaGen Therapeutics Phase II Cellular chemoreceptor stimulants Intranasal
PRAX-114 Praxis Precision Medicines Phase II / III GABA modulators Oral
REL-1017 Relmada Therapeutic Phase III NMDA receptor antagonists Oral
Caplyta Intracellular therapies Phase III Glutamate modulator Oral

Sample request to find out more @ Major Depressive Disorders Pipeline Analysis, Key Companies and Futuristic Trends

Therapeutic evaluation of major depressive disorder

The Major Depressive Disorders Pipeline report offers in-depth information of the active pipeline assets segmented by stage, product type, route of administration, molecule type, target, and mechanism of action.

By product type

By step

  • Discovery
  • Pre-clinic
  • INDIANA
  • Phase I
  • Phase II
  • Phase III
  • Pre-registration

By molecule type

  • Bispecific antibody
  • Peptides
  • Small molecule
  • Genetical therapy

By route of administration

  • Oral
  • Subcutaneous
  • Intranasal
  • Intramuscular

By mechanism of action

  • Dopamine D2 receptor agonist
  • Serotonin 1A receptor agonists
  • Glutamate modulator
  • NMDA receptor modulators
  • Adrenergic receptor antagonists
  • GABA A receptor modulators
  • Orexin type 2 receptor antagonists

By targets

  • Dopamine D2 receptor
  • Serotonin 1A receptor
  • Glutamate
  • NMDA receiver
  • Adrenergic receptor
  • GABAA receiver
  • Type 2 orexin receptor

Contact our sales manager for Informative business decisions, licensing services and consulting solutions

Scope of the report

Blanket: Global
Key players: Axsome Therapeutics, Luye Pharma, Sage Therapeutics, Chase Therapeutics, Minerva Biosciences, Relmada Therapeutics, Praxis Precision Medicines, Intra-Cellular Therapies, Gedeon Richter, Small Pharma, Clexio Biosciences, VistaGen Therapeutics, among others.

Key pipeline therapies for major depressive disorder: Vraylar, PDC-1421, AV-101, AXS-05, Pramipexole, SAGE-217, LY03005, Seltorexant, PH10, PRAX-114, REL-1017, Caplyta, Cariprazine, SPL026, CLE-100, among others.

To reach @ Major depressive disorders pipeline: new therapies and emerging technologies

Contents

1 Presentation of the report
2 Major depressive disorder illness overview
3 Prospects for the Major Depressive Disorders Pipeline
4 Comparative analysis
5 Therapeutics for Clinical Major Depressive Disorder
6 Therapeutics for non-clinical major depressive disorder
7 Analysis of the therapeutic pipeline for major depressive disorder
8 Inactive Major Depressive Disorders Pipeline Products
9 Annex
ten Methodology of the report
11 Consulting services
12 Disclaimer
13 About DelveInsight

Visit to learn more about what’s covered @ Major depressive disorders Emerging therapies, treatments and ongoing clinical trials

Associated reports

Complex Regional Pain Syndrome Market
DelveInsight’s’Complex Regional Pain Syndrome (CRPS) Market Overview, Epidemiology and Market Forecast-2030‘ report.

Concussion Market
DelveInsight’s “Concussion Market Overview, Epidemiology and Market Forecast-2030” report.

Memory Disorders Market
DelveInsight’s “Memory Disorders – Market Overview, Epidemiology, and Market Forecast-2030” report.

Multiple Organ Dysfunction Syndrome Market
DelveInsight’s “Multiple Organ Dysfunction Syndrome Market Overview, Epidemiology and Market Forecast-2030” report.

Multiple Sclerosis Market
DelveInsight’s “Multiple Sclerosis Market Overview, Epidemiology and Market Forecast-2030” report.

Drug overdose market
DelveInsight’s ” Drug Overdose – Market Overview, Epidemiology and Market Forecast-2030” report.

Narcolepsy market
DelveInsight’s’Narcolepsy Market Overview, Epidemiology and Market Forecast-2030‘ report..

Bipolar Disorder (Manic Depression) Market
DelveInsight’s’Bipolar Disorder (Manic Depression) – Market Overview, Epidemiology and Market Forecast-2030‘ report.

Postpartum Depression Market
DelveInsight report on “Postpartum Depression (PPD) – Market Overview, Epidemiology and Market Forecast – 2030”.

Treatment Resistant Depression Market
DelveInsight’s “Treatment Resistant Depression Market Overview, Epidemiology and Market Forecast-2030“report offer.

Suggested reading

Mental health issues
Bipolar Depression Market
Depression and societal mental health
Schizophrenia market dynamics

On SearchInsight

DelveInsight is a leading business consulting and market research firm focused exclusively on the life sciences. It supports pharmaceutical companies by providing them with complete end-to-end solutions to improve their performance. Get hassle-free access to all healthcare and pharmaceutical market research reports through our subscription platform PharmaDelve.

For more information visit Pharmaceutical, medical and biotechnology news

        


Source link

]]>
https://1000webu.com/major-depressive-disorders-pipeline-insights-into-leadership/feed/ 0
The North American market for big data and business analytics is https://1000webu.com/the-north-american-market-for-big-data-and-business-analytics-is/ https://1000webu.com/the-north-american-market-for-big-data-and-business-analytics-is/#respond Wed, 25 Aug 2021 06:44:35 +0000 https://1000webu.com/the-north-american-market-for-big-data-and-business-analytics-is/ Portland, OR, August 25, 2021 (GLOBE NEWSWIRE) – According to the report published by Allied Market Research, the North American Big Data and Business Analytics Market was pegged at $ 98.07 billion in 2020 and is expected to reach $ 169.91 billion by 2028, registering a CAGR of 7.5% from 2021 to 2028. The report […]]]>

Portland, OR, August 25, 2021 (GLOBE NEWSWIRE) – According to the report published by Allied Market Research, the North American Big Data and Business Analytics Market was pegged at $ 98.07 billion in 2020 and is expected to reach $ 169.91 billion by 2028, registering a CAGR of 7.5% from 2021 to 2028. The report provides in-depth analysis of the main investment pockets , top winning strategies, drivers and opportunities, market size and estimates, competitive landscape and changing market trends.

The increasing adoption of big data analytics software by multiple organizations, the increasing demand for cloud-based big data analytics software among SMBs, and the many benefits provided by big data and data solutions. business analytics are driving the growth of the North American big data and business analytics market. On the other hand, the high cost of implementation and the lack of skilled labor hamper growth to some extent. However, emerging trends such as social media analytics are expected to create lucrative opportunities in the industry.

Download a sample report (229 PDF pages with information) at: https://www.alliedmarketresearch.com/request-sample/12734

COVID-19 scenario-

  • The trend of working from home has led to a huge amount of opportunities for data analytics thus positively impacting the North American big data and business analytics market.
  • This trend is also expected to continue after the pandemic, as organizations have started integrating business analytics solutions to improve data security and completely streamline business productivity.

Get a detailed analysis of the impact of COVID-19 on the North American Big Data and Business Analytics Market: https://www.alliedmarketresearch.com/request-for-customization/12734

The North American Big Data and Business Analytics Market is analyzed by component, mode of deployment, analytics tool, industry vertical, and country. On a component basis, the services segment contributed almost half of the total market share in 2020 and is expected to lead by 2028. The software segment, meanwhile, is reportedly citing the fastest CAGR 9.4% from 2021 to 2028..

Based on industry vertical, the BFSI segment accounted for nearly one-fifth of total market revenue by 2020 share and is expected to reign on the roost by 2028. The healthcare segment, however, would experience the fastest growth of 10.2% compared to 2021 to 2028.

Depending on the country, the United States held the largest share in 2020, generating 95% of the North American market for big data and business analytics. At a time, the market across Canada would cite the fastest CAGR of 12.4% during the forecast period.

Leading market players analyzed in the North America Big Data and Business Analytics Market report include Fair Isaac Corporation, IBM Corporation, TIBCO Software Inc., Microsoft Corporation, Amazon Web Services, Oracle Corporation, SAP SE, SAS Institute Inc., Hewlett Packard Enterprise Development LP, and Teradata Corporation. These market players have adopted different strategies including partnership, expansion, collaboration, joint ventures and others to strengthen their status in the industry.

For Purchase Inquiry: https://www.alliedmarketresearch.com/purchase-enquiry/12734

Access AVENUE – A subscription-based library (premium on-demand, subscription-based pricing model) at:

https://www.alliedmarketresearch.com/library-access

Street is a user-based library of global market reports database, provides comprehensive reports regarding the world’s largest emerging markets. It further provides electronic access to all available industry reports a snap. By offering essential business information on various industries, economies and end users around the world, Avenue ensures that registered members get a simple and one-stop gateway to their all-inclusive needs.

Avenue Library Subscription | Request 14-day free trial before purchasing:

https://www.alliedmarketresearch.com/avenue/trial/starter

About Us:

Allied Market Research (AMR) is a full-service market research and business consulting division of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global businesses as well as medium and small businesses with unmatched quality of “market research reports” and “business intelligence solutions”. AMR has a focused vision to provide business information and advice to help its clients make strategic business decisions and achieve sustainable growth in their respective market area.

Pawan Kumar, CEO of Allied Market Research, leads the organization towards providing high quality data and information. We have professional relationships with various companies, which helps us extract market data which helps us generate accurate research data tables and confirm the highest accuracy in our market forecast. Each of the data presented in the reports we publish is extracted through primary interviews with senior officials of the main companies in the field concerned. Our secondary data sourcing methodology includes in-depth online and offline research and discussions with industry-savvy professionals and analysts.

        


Source link

]]>
https://1000webu.com/the-north-american-market-for-big-data-and-business-analytics-is/feed/ 0
How to stand out in the inbox: BIMI explained – General – Services https://1000webu.com/how-to-stand-out-in-the-inbox-bimi-explained-general-services/ https://1000webu.com/how-to-stand-out-in-the-inbox-bimi-explained-general-services/#respond Mon, 23 Aug 2021 01:04:14 +0000 https://1000webu.com/how-to-stand-out-in-the-inbox-bimi-explained-general-services/ While the process of implementing BIMI is not straightforward, it is well worth the investment.photo by Stephen Phillips – Hostreviews.co.uk to Unsplash How can marketers make sure their emails stand out in increasingly crowded inboxes for the right reasons and enjoy the trust of their subscribers? Enter BIMI. A standard 320 billion emails are sent […]]]>



While the process of implementing BIMI is not straightforward, it is well worth the investment.
photo by Stephen Phillips – Hostreviews.co.uk to Unsplash

How can marketers make sure their emails stand out in increasingly crowded inboxes for the right reasons and enjoy the trust of their subscribers? Enter BIMI.

A standard 320 billion emails are sent and received around the world every day, with spam accounting for 85% of that figure. Given that consumers receive so many emails daily – and this is unlikely to change given that email is the preferred and most used channel for brands to engage with customers (72%) – standing out in crowded inboxes is a major challenge for marketers.

In addition to increased competition, ensuring that your brand’s messages appear to be authentic and trustworthy to the recipients (i.e. not spam) is another hurdle for marketers to overcome. marketing. Consumers are more likely to open and interact with messages they trust, with the 2021 DMA Consumer Email Tracker finding that ‘brand recognition’ is the most important factor in determining whether recipients will open an email , even more than having the perfect subject line. . This is understandable given that phishing, identity theft and fraudulent emails are on the rise.

What is BIMI?

BIMI stands for Brand Indicators for Message Identification and is an email specification that allows the use of brand-controlled logos in supporting email clients. In practice, this means that sender logos are displayed in subscribers’ inboxes, resulting in instant brand recognition, which we know results in higher open rates.

BIMI has been around since 2019, but it received a lot of attention in 2020 when Google launched a trial in Gmail. Due to its success, Google announced in July 2021 that Gmail would permanently support BIMI technology. Gmail joins Yahoo and Fastmail in BIMI support, making it available in around 2 billion inboxes. This increased adoption of BIMI presents a significant opportunity for senders to differentiate their messages in the inbox.

What are the advantages of BIMI?

Stand out in crowded inboxes. With BIMI adoption just starting to increase, its implementation is a great way to stand out in crowded inboxes and differentiate yourself from other senders. Marketers who act quickly can be among the first to use BIMI in Gmail, giving them a real competitive advantage. It’s more important than ever as a new one report by Validity Inc. e-mail volumes found will hit record highs this year.

BIMI can have a positive impact on reputation. Increased recognition and trust leads to fewer unsubscribes and spam complaints, which in turn improves sender reputation and deliverability.

For email providers that support BIMI, this will add an extra layer of authenticity to your messages, improving the likelihood of your emails being delivered.

Leverage your investment in DMARC. To be eligible for BIMI, you must first implement a strict DMARC (Domain-based Message Authentication, Reporting and Conformance) policy. This has huge benefits for your brand’s email security as it helps protect your company’s email domain from email spoofing, phishing scams, and other cybercrimes. BIMI highlights and rewards your investment in DMARC by increasing your brand impressions in the inbox. It’s likely we’ll likely see smart senders informing their subscribers about this, with messages like “If you don’t see our official logo, don’t trust the email!” “

How to get started with BIMI

The benefits of BIMI are considerable, and although its use is set to become more widespread in light of Google’s recent announcement, early adopters are expected to gain a significant competitive advantage. So, to implement BIMI, follow these steps.

  1. Implement and enforce a strong DMARC policy. DMARC is a strict protocol used by email domains to determine what happens if an email fails the authentication test. BIMI requires that you have a DMARC rejection policy or 100% quarantine for emails that fail this test. If you are already working with this level of application, you are well on your way to a successful BIMI implementation. If not, you need to strengthen your email authentication by creating a DMARC record.
  2. Create a BIMI record. Once you have the appropriate DMARC policy in place, you will need to publish your domain’s BIMI record in the Domain Name System (DNS).
  1. Obtain a VMC (Certified Mark Certificate). While not mandatory for all email providers, Google does require brands to obtain a VMC to display their logo in Gmail inboxes. Thus, to take advantage of Gmail’s new BIMI support (and with 43% email market share, we assume you like), you will need to go through the verification process with a Certified Authority (CA) that proves your right to use the image. Your logo must be a registered trademark, and this will be validated during the screening process. Keep in mind that some email providers support BIMI without VMC. Therefore, if you choose to skip this last step, it is still useful to publish a “self-asserted” BIMI record.

While the process of implementing BIMI is not straightforward, it is well worth the investment. Those who get started now will enjoy an early adoption benefit, as well as the ongoing and meaningful benefits that BIMI offers.

Guy hanson, Vice President of Customer Engagement at Validity Inc.


Source link

]]>
https://1000webu.com/how-to-stand-out-in-the-inbox-bimi-explained-general-services/feed/ 0
Pharmaceutical Companies Lead Revenue Growth in First Quarter FY22: ICICI Direct Research https://1000webu.com/pharmaceutical-companies-lead-revenue-growth-in-first-quarter-fy22-icici-direct-research/ https://1000webu.com/pharmaceutical-companies-lead-revenue-growth-in-first-quarter-fy22-icici-direct-research/#respond Sun, 22 Aug 2021 14:01:00 +0000 https://1000webu.com/pharmaceutical-companies-lead-revenue-growth-in-first-quarter-fy22-icici-direct-research/ Business profits for April-June were strong despite the second wave of Covid-19 and a report from ICICI Direct Research showed that revenue growth in the quarter was led by pharmaceutical companies. The report noted that revenue growth has also been supported by the resilient IT industry through increased digital spending and the resurgence of the […]]]>

Business profits for April-June were strong despite the second wave of Covid-19 and a report from ICICI Direct Research showed that revenue growth in the quarter was led by pharmaceutical companies.

The report noted that revenue growth has also been supported by the resilient IT industry through increased digital spending and the resurgence of the metals space which has seen strong product achievements.

“In the first quarter of fiscal 22, revenue growth on a QoQ basis was led by the pharmaceutical space, primarily the domestic brand formulations segment,” the recent report said.

The laggard this time was the automotive space amid a 34% drop in auto sales volume in QoQ due to limited dealer activity and the capital goods field due to seasonality. , the fourth quarter being a very seasonal quarter.

During the quarter, in the IT space, Level I companies grew 5.2% in QoQ while Level II companies grew 8.2% in QoQ.

Additionally, one of the key themes observed in the first quarter results was that there was much higher visibility of revenue based on strong sales and hiring trends.

The acceleration of the order book and transaction pipeline continues to be strong against a backdrop of increasing corporate spending on cloud migration and digital technologies.

The report noted that corporate earnings held up in April-June 2021 (T1FY22) amid the resurgence of pan-India Covid. It was mainly due to a limited impact on economic activity, with Corporate India having largely operated unabated during the second wave of Covid.

At the level of the Nifty index, excluding financial services, the decrease in net sales was limited to 7.5% on a sequential basis (QoQ) with a low base impacted by Covid in the first quarter of fiscal 21, making the Rather redundant year-on-year comparison, he said.

On the operating profit front, the decline was limited to 6.7 percent amid a 15 basis point expansion in EBITDA margins to 19.2 percent.

At the PAT level, net income was down 14.5% qoq, due to a double-digit qoq decline in other income. With state-specific release underway, management commentary was optimistic and hoped for a strong rebound for the remainder of the year (9MFY22E).

–IANS

rrb / sn / vd

(Only the title and image of this report may have been reworked by Business Standard staff; the rest of the content is automatically generated from a syndicated feed.)

Dear reader,

Business Standard has always strived to provide up-to-date information and commentary on developments that matter to you and have broader political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering has only strengthened our resolve and commitment to these ideals. Even in these difficult times resulting from Covid-19, we remain committed to keeping you informed and updated with credible news, authoritative views and cutting edge commentary on relevant current issues.
However, we have a demand.

As we fight the economic impact of the pandemic, we need your support even more so that we can continue to provide you with more quality content. Our subscription model has received an encouraging response from many of you who have subscribed to our online content. More subscriptions to our online content can only help us achieve the goals of providing you with even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practice the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital editor


Source link

]]>
https://1000webu.com/pharmaceutical-companies-lead-revenue-growth-in-first-quarter-fy22-icici-direct-research/feed/ 0